Masked polycythemia vera: analysis of a single center cohort of 2480 red cell masses.
作者信息
Maslah Nabih, Soret Juliette, Dosquet Christine, Vercellino Laetitia, Belkhodja Célia, Schlageter Marie-Hélène, Cassinat Bruno, Kiladjian Jean-Jacques, Chomienne Christine, Giraudier Stephane
机构信息
APHP, Hôpital Saint Louis, Service de Biologie Cellulaire.
France Intergroupe des syndromes Myéloprolifératifs (FIM).
出版信息
Haematologica. 2020 Mar;105(3):e95-e97. doi: 10.3324/haematol.2018.215582. Epub 2019 Aug 14.
Abstract
摘要
相似文献
1
Masked polycythemia vera: analysis of a single center cohort of 2480 red cell masses.隐匿性真性红细胞增多症：对2480例红细胞容量的单中心队列分析
Haematologica. 2020 Mar;105(3):e95-e97. doi: 10.3324/haematol.2018.215582. Epub 2019 Aug 14.
2
[New criteria for differential diagnosis of polycythemia vera and erythrocytosis].[真性红细胞增多症和红细胞增多症鉴别诊断的新标准]
Gematol Transfuziol. 1992 Sep-Oct;37(9-10):40-2.
3
Polycythemia vera masked due to severe iron deficiency anemia.真性红细胞增多症因严重缺铁性贫血而被掩盖。
Hematol Oncol Stem Cell Ther. 2018 Mar;11(1):38-40. doi: 10.1016/j.hemonc.2016.08.007. Epub 2016 Sep 2.
4
Diagnosis of polycythemia vera in an anemic patient.贫血患者真性红细胞增多症的诊断。
South Med J. 2000 Jul;93(7):710-2.
5
The WHO diagnostic criteria for polycythemia vera-role of red cell mass versus hemoglobin/hematocrit level and morphology.世界卫生组织真性红细胞增多症诊断标准-红细胞质量与血红蛋白/红细胞压积水平和形态的关系。
Ann Hematol. 2018 Sep;97(9):1581-1590. doi: 10.1007/s00277-018-3344-3. Epub 2018 May 1.
6
A Clue in JAK2: Masked Polycythemia Vera.JAK2中的一个线索：隐匿性真性红细胞增多症。
Am J Med. 2016 Oct;129(10):1051-3. doi: 10.1016/j.amjmed.2016.06.030. Epub 2016 Jul 15.
7
Comments on: "Validity of rapid estimation of erythrocyte volume in the diagnosis of polycytemia vera".对《真性红细胞增多症诊断中红细胞体积快速估计的有效性》的评论
Eur J Nucl Med. 1990;17(1-2):96-7. doi: 10.1007/BF00819412.
8
Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).慢性骨髓增殖性疾病（MPD）、原发性血小板增多症（ET）、真性红细胞增多症（PV）和慢性特发性骨髓纤维化（CIMF）的现行诊断标准。
Pathol Biol (Paris). 2007 Mar;55(2):92-104. doi: 10.1016/j.patbio.2006.06.002. Epub 2006 Aug 21.
9
Relative and absolute polycythemia. How to tell them apart.相对性和绝对性红细胞增多症。如何区分它们。
Postgrad Med. 1987 Apr;81(5):285-8. doi: 10.1080/00325481.1987.11699802.
10
Microcytic polycythemia. Frequency of nonthalassemic causes.小细胞性红细胞增多症。非地中海贫血病因的发生率。
JAMA. 1977 Nov 28;238(22):2391-2. doi: 10.1001/jama.238.22.2391.
引用本文的文献
1
Old Therapy, New Questions: Rethinking Phlebotomy in a Pharmacologic Landscape.旧疗法，新问题：在药物治疗背景下重新思考放血疗法。
Pharmaceuticals (Basel). 2025 Aug 16;18(8):1212. doi: 10.3390/ph18081212.
2
Landscape of somatic mutations in myeloproliferative neoplasm in Pakistani population.巴基斯坦人群骨髓增殖性肿瘤的体细胞突变图谱。
Pak J Med Sci. 2025 Jul;41(7):2003-2009. doi: 10.12669/pjms.41.7.12129.
3
Assessment of hemoglobin mass and blood volumes at moderate altitude using carbon monoxide rebreathing method.使用一氧化碳再呼吸法评估中度海拔地区的血红蛋白含量和血容量。
Medicine (Baltimore). 2025 Jun 6;104(23):e42762. doi: 10.1097/MD.0000000000042762.
4
Polycythaemia vera.真性红细胞增多症
Nat Rev Dis Primers. 2025 Apr 17;11(1):26. doi: 10.1038/s41572-025-00608-3.
5
Dysarthria and Altered Mental Status Following Electroconvulsive Therapy (ECT) in a Patient With Polycythemia Vera: A Case Report.真性红细胞增多症患者接受电休克治疗（ECT）后出现构音障碍和精神状态改变：一例报告
Cureus. 2024 Nov 18;16(11):e73941. doi: 10.7759/cureus.73941. eCollection 2024 Nov.
6
Iron deficiency and phlebotomy in patients with polycythemia vera.真性红细胞增多症患者的缺铁与放血疗法
Int J Hematol. 2025 Jan;121(1):39-44. doi: 10.1007/s12185-024-03868-z. Epub 2024 Nov 11.
7
Molecular landscape of the gene in chronic myeloproliferative neoplasm patients from the state of Amazonas, Brazil.巴西亚马孙州慢性骨髓增殖性肿瘤患者中该基因的分子图谱。
Biomed Rep. 2023 Oct 23;19(6):98. doi: 10.3892/br.2023.1680. eCollection 2023 Dec.
8
Advances in management of primary myelofibrosis and polycythaemia vera: Implications in clinical practice.原发性骨髓纤维化和真性红细胞增多症的管理进展：对临床实践的启示
EJHaem. 2023 Jun 7;4(3):779-791. doi: 10.1002/jha2.734. eCollection 2023 Aug.
9
Polycythemia Vera: Thinking Beyond the Hematocrit.真性红细胞增多症：超越血细胞比容的思考
J Adv Pract Oncol. 2023 Jul;14(5):405-413. doi: 10.6004/jadpro.2023.14.5.5. Epub 2023 Jul 1.
10
Contribution of lowered hemoglobin threshold value in the diagnosis of polycythemia vera: Comparison of 2016 and 2008 WHO criteria.降低血红蛋白阈值在真性红细胞增多症诊断中的作用：2016 年和 2008 年 WHO 标准的比较。
Medicine (Baltimore). 2023 Aug 4;102(31):e34462. doi: 10.1097/MD.0000000000034462.
本文引用的文献
1
The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion.2016 年世界卫生组织（WHO）髓系增殖性肿瘤分类和诊断标准：文件摘要和深入讨论。
Blood Cancer J. 2018 Feb 9;8(2):15. doi: 10.1038/s41408-018-0054-y.
2
European LeukemiaNet study on the reproducibility of bone marrow features in masked polycythemia vera and differentiation from essential thrombocythemia.欧洲白血病网络研究在蒙面真性红细胞增多症和特发性血小板增多症中的骨髓特征的可重复性及两者的鉴别诊断。
Am J Hematol. 2017 Oct;92(10):1062-1067. doi: 10.1002/ajh.24837. Epub 2017 Jul 29.
3
Polycythemia vera masked due to severe iron deficiency anemia.真性红细胞增多症因严重缺铁性贫血而被掩盖。
Hematol Oncol Stem Cell Ther. 2018 Mar;11(1):38-40. doi: 10.1016/j.hemonc.2016.08.007. Epub 2016 Sep 2.
4
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.2016 年版世界卫生组织髓系肿瘤和急性白血病分类。
Blood. 2016 May 19;127(20):2391-405. doi: 10.1182/blood-2016-03-643544. Epub 2016 Apr 11.
5
Rethinking the diagnostic criteria of polycythemia vera.重新思考真性红细胞增多症的诊断标准。
Leukemia. 2014 Jun;28(6):1191-5. doi: 10.1038/leu.2013.380. Epub 2013 Dec 19.
6
Evaluation of WHO criteria for diagnosis of polycythemia vera: a prospective analysis.评估世界卫生组织诊断真性红细胞增多症的标准：一项前瞻性分析。
Blood. 2013 Sep 12;122(11):1881-6. doi: 10.1182/blood-2013-06-508416. Epub 2013 Jul 30.
7
Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis.布加综合征和门静脉血栓形成中的骨髓增殖性肿瘤：一项荟萃分析。
Blood. 2012 Dec 13;120(25):4921-8. doi: 10.1182/blood-2011-09-376517. Epub 2012 Oct 4.
8
Red cell mass measurement in patients with clinically suspected diagnosis of polycythemia vera or essential thrombocythemia.红细胞容量测量在临床疑似真性红细胞增多症或原发性血小板增多症患者中的应用。
Haematologica. 2012 Nov;97(11):1704-7. doi: 10.3324/haematol.2012.067348. Epub 2012 Jun 11.
9
Classification of myeloproliferative disorders in the JAK2 era: is there a role for red cell mass?JAK2 时代骨髓增殖性疾病的分类：红细胞容量有作用吗？
Leukemia. 2008 Feb;22(2):452-3. doi: 10.1038/sj.leu.2404908. Epub 2007 Aug 23.
10
Initial (latent) polycythemia vera with thrombocytosis mimicking essential thrombocythemia.初始（潜伏性）真性红细胞增多症伴血小板增多，酷似原发性血小板增多症。
Acta Haematol. 2005;113(4):213-9. doi: 10.1159/000084673.
Zotero 插件